MLB

MLB bans Mariners' Tim Beckham 80 games for steroid use

Seattle Mariners infielder Tim Beckham has been suspended 80 games as part of baseball's joint drug agreement after testing positive for stanozolol, a banned performance enhancer, Major League Baseball announced Tuesday.

Infielder claims product he received from 'trusted source' was safe to take

Mariners infielder Tim Beckham will sit out the balance of the season after testing positive for stanozolol, a banned performance enhancer. (Abbie Parr/Getty Images)

Seattle Mariners infielder Tim Beckham has been suspended 80 games as part of baseball's joint drug agreement after testing positive for stanozolol, a banned performance enhancer, Major League Baseball announced Tuesday.

Beckham's suspension is effective immediately and ends his season.

In a statement released through the players' association, Beckham says he took a product from a "trusted source, who had advised it was safe to take. Regrettably, the product was tainted." Beckham says he appealed but an independent arbitrator upheld the suspension.

"I accept full responsibility for putting myself in this situation," Beckham said.

Beckham was hitting .237 in 88 games this season for Seattle with 15 home runs and 47 runs batted in.

The No. 1 overall draft pick in 2008 was a starter at the beginning of the year but had moved into a utility role over the past couple of months, playing all four infield positions and in left field.

Comments

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.